Liam Condon Purchases 30 Shares of Johnson Matthey PLC (LON:JMAT) Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon bought 30 shares of Johnson Matthey stock in a transaction dated Wednesday, January 22nd. The shares were bought at an average cost of GBX 1,362 ($17.01) per share, with a total value of £408.60 ($510.18).

Johnson Matthey Stock Up 0.7 %

JMAT opened at GBX 1,376 ($17.18) on Friday. Johnson Matthey PLC has a 12 month low of GBX 1,295.54 ($16.18) and a 12 month high of GBX 1,917.07 ($23.94). The company has a 50 day moving average of GBX 1,378.95 and a 200 day moving average of GBX 1,509.48. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 63.15. The company has a market cap of £2.40 billion, a PE ratio of 2,372.41, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.

Johnson Matthey (LON:JMATGet Free Report) last issued its quarterly earnings data on Wednesday, November 27th. The company reported GBX 57.40 ($0.72) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.39%. On average, sell-side analysts expect that Johnson Matthey PLC will post 173.4112903 EPS for the current year.

Johnson Matthey Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Tuesday, February 4th. Stockholders of record on Thursday, December 5th will be given a dividend of GBX 22 ($0.27) per share. The ex-dividend date is Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s dividend payout ratio (DPR) is presently 13,275.86%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.47) price objective on shares of Johnson Matthey in a report on Tuesday, December 17th. Berenberg Bank cut their price target on Johnson Matthey from GBX 1,650 ($20.60) to GBX 1,500 ($18.73) and set a “hold” rating for the company in a research note on Thursday, November 28th.

Read Our Latest Stock Report on JMAT

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Articles

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.